[
    {
        "text": "[ ♪INTRO ]",
        "start": 0.0,
        "duration": 10.16
    },
    {
        "text": "This episode was filmed on April 30, 2020.",
        "start": 11.1,
        "duration": 2.02
    },
    {
        "text": "If we have more recent episodes about vaccines\nor COVID-19, they will be linked in the description.",
        "start": 13.12,
        "duration": 4.99
    },
    {
        "text": "You might have heard that the COVID-19 crisis won’t\ntruly be under control until we have a vaccine",
        "start": 18.11,
        "duration": 5.41
    },
    {
        "text": "-- though increased testing and effective\ntreatments are gonna go a long way.",
        "start": 23.52,
        "duration": 3.82
    },
    {
        "text": "You might also be hearing that even though\nscientists are working on a bunch of different",
        "start": 27.34,
        "duration": 3.769
    },
    {
        "text": "vaccines right now, it’ll be more than\na year until we the public can have one",
        "start": 31.109,
        "duration": 4.401
    },
    {
        "text": "-- and that is a best-case.",
        "start": 35.51,
        "duration": 1.93
    },
    {
        "text": "This is frustrating...so you would not be\nthe only person asking WHY WHY WHY this is.",
        "start": 37.44,
        "duration": 6.389
    },
    {
        "text": "Well, there are good reasons.",
        "start": 43.829,
        "duration": 2.091
    },
    {
        "text": "But to understand them, we first have to understand\na bit about how the immune system works.",
        "start": 45.92,
        "duration": 4.27
    },
    {
        "text": "And, like, that’s not super simple, but\nit’s also fascinating and weird and going",
        "start": 50.19,
        "duration": 3.49
    },
    {
        "text": "to come in handy on more days than just this\none.",
        "start": 53.68,
        "duration": 2.719
    },
    {
        "text": "So listen up.",
        "start": 56.399,
        "duration": 1.0
    },
    {
        "text": "Our immune system has two main prongs: innate\nand adaptive immunity.",
        "start": 57.399,
        "duration": 2.98
    },
    {
        "text": "But the key player here is the adaptive part.",
        "start": 60.379,
        "duration": 3.02
    },
    {
        "text": "Our adaptive immune system responds to things\nthat make us sick, and remembers them for",
        "start": 63.399,
        "duration": 4.321
    },
    {
        "text": "later so that it can keep us from getting\nsick a second time.",
        "start": 67.72,
        "duration": 3.63
    },
    {
        "text": "Vaccines aim to jump in, before an infection,\nto teach the adaptive immune system what an",
        "start": 71.35,
        "duration": 4.54
    },
    {
        "text": "infectious agent, or pathogen, looks like,\nso we don’t get sick with it at all.",
        "start": 75.89,
        "duration": 5.04
    },
    {
        "text": "A vaccine shows your immune system a picture\nof the scary invader, and then it remembers",
        "start": 80.93,
        "duration": 5.32
    },
    {
        "text": "it as a baddie.",
        "start": 86.25,
        "duration": 1.5
    },
    {
        "text": "It’s actually more complicated than that.",
        "start": 87.75,
        "duration": 2.32
    },
    {
        "text": "This is all happening at a molecular level...your",
        "start": 90.07,
        "duration": 2.81
    },
    {
        "text": "immune system can’t “see” anything,\nit doesn’t have eyes.",
        "start": 92.88,
        "duration": 3.18
    },
    {
        "text": "So isn’t actually responding to the pathogen\nas a whole, it’s noticing and responding",
        "start": 96.06,
        "duration": 4.419
    },
    {
        "text": "to specific proteins found on invaders floating\naround your body, or, in some cases, on the",
        "start": 100.479,
        "duration": 5.57
    },
    {
        "text": "surface of an already-infected cell.",
        "start": 106.049,
        "duration": 2.971
    },
    {
        "text": "Any protein that your immune system identifies\nas worthy of action is what we call an “antigen.”",
        "start": 109.02,
        "duration": 4.84
    },
    {
        "text": "And the cells that are going to respond when",
        "start": 113.86,
        "duration": 2.189
    },
    {
        "text": "antigens are identified is a type of white\nblood cell called lymphocytes.",
        "start": 116.049,
        "duration": 4.121
    },
    {
        "text": "Each lymphocyte recognizes a specific antigen\nthrough a structure called an antigen receptor.",
        "start": 120.17,
        "duration": 5.18
    },
    {
        "text": "But how can your immune system have an antigen\nreceptor for a protein it’s never seen?",
        "start": 125.35,
        "duration": 5.07
    },
    {
        "text": "Well, this is where it gets crazy.",
        "start": 130.42,
        "duration": 2.56
    },
    {
        "text": "It’s basically a brute-force guessing game...like\na computer program hacking a password: you",
        "start": 132.98,
        "duration": 5.581
    },
    {
        "text": "try a gazillion words until one of them locks\nin and you can use that password to get into somebody’s account.",
        "start": 138.561,
        "duration": 5.479
    },
    {
        "text": "Basically, your body makes /trillions/ of\nlymphocytes with a bunch of very slightly different receptors.",
        "start": 144.22,
        "duration": 5.78
    },
    {
        "text": "And sooner or later, one of them is likely\nto eventually lock onto any given bug.",
        "start": 150.2,
        "duration": 4.099
    },
    {
        "text": "And once it does, it immediately explodes\nin population cloning itself over and over",
        "start": 154.299,
        "duration": 5.771
    },
    {
        "text": "and over again into an army of two types of\ncells.",
        "start": 160.07,
        "duration": 4.22
    },
    {
        "text": "Some are effector cells that make virus-neutralizing\nantibodies or kill off infected cells to prevent",
        "start": 164.29,
        "duration": 6.03
    },
    {
        "text": "the virus from replicating -- they’re meant\nto stop the present infection.",
        "start": 170.32,
        "duration": 4.41
    },
    {
        "text": "The other type can hold a grudge for years\n– memory cells that will mount an attack",
        "start": 174.73,
        "duration": 6.36
    },
    {
        "text": "should the pathogen ever infect your body\nagain.",
        "start": 181.09,
        "duration": 2.69
    },
    {
        "text": "The goal of a vaccine is to skip right to\nthat memory part, without causing serious",
        "start": 183.78,
        "duration": 4.639
    },
    {
        "text": "side effects in the patient.",
        "start": 188.419,
        "duration": 1.331
    },
    {
        "text": "But there’s more than one way to do that...so\nthere is more than one type of vaccine.",
        "start": 189.75,
        "duration": 4.829
    },
    {
        "text": "And because COVID-19 is a relatively new disease,\nit’s worth trying a little bit of everything",
        "start": 194.579,
        "duration": 4.551
    },
    {
        "text": "to see what actually sticks against the SARS-CoV-2\nvirus.",
        "start": 199.13,
        "duration": 3.199
    },
    {
        "text": "One option is live attenuated vaccines, which",
        "start": 202.329,
        "duration": 3.482
    },
    {
        "text": "are the first type of vaccines ever discovered.",
        "start": 205.811,
        "duration": 2.109
    },
    {
        "text": "They’re still used today for diseases like\nmeasles, mumps, rubella, and chicken pox.",
        "start": 207.92,
        "duration": 5.03
    },
    {
        "text": "They contain living virus, but don’t worry\n-- it’s been weakened.",
        "start": 212.95,
        "duration": 3.83
    },
    {
        "text": "That’s what the “attenuated” part refers\nto.",
        "start": 216.78,
        "duration": 3.239
    },
    {
        "text": "Attenuated viruses are created by breeding\nthem in an environment that is different from",
        "start": 220.019,
        "duration": 3.841
    },
    {
        "text": "what they encounter in a human being, like\nin low temperatures or in a different species of animal.",
        "start": 223.86,
        "duration": 5.36
    },
    {
        "text": "When that virus is then given to a human,\nit still retains the tell-tale antigens of",
        "start": 229.48,
        "duration": 4.22
    },
    {
        "text": "its dangerous ancestor that will produce the\nright memory immune cells we want.",
        "start": 233.709,
        "duration": 4.241
    },
    {
        "text": "But it has spent so much time adapting to\na changed environment that it’s not very",
        "start": 237.95,
        "duration": 4.58
    },
    {
        "text": "good at virusing inside a human any more\n-- so it won’t replicate enough to cause disease.",
        "start": 242.53,
        "duration": 6.35
    },
    {
        "text": "One project in the works to produce a live",
        "start": 248.98,
        "duration": 1.42
    },
    {
        "text": "attenuated SARS-CoV-2 vaccine is a joint effort\nbetween the Indian Serum Institute and the",
        "start": 250.41,
        "duration": 4.63
    },
    {
        "text": "US-based drug research company Codagenix.",
        "start": 255.04,
        "duration": 2.4
    },
    {
        "text": "It’s already undergoing animal testing,\nand the companies may launch human trials in the fall.",
        "start": 257.44,
        "duration": 5.16
    },
    {
        "text": "Live-attenuated vaccines usually produce strong\nimmunity, and they tend to be one-and-done",
        "start": 262.68,
        "duration": 4.94
    },
    {
        "text": "-- no booster shots.",
        "start": 267.62,
        "duration": 1.35
    },
    {
        "text": "But they also have some drawbacks.",
        "start": 268.97,
        "duration": 1.23
    },
    {
        "text": "They need to be kept at a low temperature\nand protected from light, which can damage them.",
        "start": 270.2,
        "duration": 4.84
    },
    {
        "text": "That makes them harder to manufacture and\ndistribute.",
        "start": 275.22,
        "duration": 1.94
    },
    {
        "text": "Plus, in patients with a weakened immune system,\nthe attenuated virus will occasionally replicate",
        "start": 277.16,
        "duration": 4.53
    },
    {
        "text": "enough to actually cause an infection or even\nspread to other people.",
        "start": 281.69,
        "duration": 3.65
    },
    {
        "text": "To solve those problems, scientists developed\nour second kind of vaccine inactivated vaccines,",
        "start": 286.34,
        "duration": 5.2
    },
    {
        "text": "where the pathogen is killed before it’s\ninjected into the human body.",
        "start": 291.54,
        "duration": 4.43
    },
    {
        "text": "There are plenty of inactivated vaccines out\nthere, like the ones used for Hepatitis A and rabies.",
        "start": 295.97,
        "duration": 4.59
    },
    {
        "text": "Inactivated vaccines are /much/ safer for\npatients with a weakened immune system, but",
        "start": 300.72,
        "duration": 4.24
    },
    {
        "text": "what makes them safer also makes them a little\nweaker.",
        "start": 304.96,
        "duration": 3.44
    },
    {
        "text": "The killed-off virus doesn’t replicate in\nthe body, so however much pathogen you put",
        "start": 308.4,
        "duration": 4.67
    },
    {
        "text": "into the injection, that’s all the training\nthat your immune system is going to get!",
        "start": 313.07,
        "duration": 4.18
    },
    {
        "text": "That means multiple doses will be necessary,\nand with some inactivated vaccines, you may",
        "start": 317.25,
        "duration": 4.66
    },
    {
        "text": "may later need periodic booster shots to kick\nthat immunological memory back into gear.",
        "start": 321.91,
        "duration": 4.21
    },
    {
        "text": "At least four inactivated COVID-19 vaccines\nare currently in development, two of which,",
        "start": 326.12,
        "duration": 5.16
    },
    {
        "text": "created by a pair of Chinese companies, have\nalready been approved for human trials.",
        "start": 331.28,
        "duration": 4.1
    },
    {
        "text": "Live-attenuated and inactivated vaccines have\none thing in common: to make them, you first",
        "start": 335.38,
        "duration": 4.86
    },
    {
        "text": "need to grow a lot of the pathogen in a lab.",
        "start": 340.24,
        "duration": 2.7
    },
    {
        "text": "But that’s not always easy, because for\nsome germs, this process is just too expensive,",
        "start": 342.94,
        "duration": 4.97
    },
    {
        "text": "time-consuming or dangerous.",
        "start": 347.91,
        "duration": 1.85
    },
    {
        "text": "Which brings us to subunit vaccines.",
        "start": 349.76,
        "duration": 3.0
    },
    {
        "text": "Subunit vaccines only use /part/ of the pathogen.",
        "start": 352.76,
        "duration": 3.85
    },
    {
        "text": "Researchers choose an antigen that will be\nlikely to provoke an immune response, and",
        "start": 356.61,
        "duration": 3.83
    },
    {
        "text": "then grow it up in bacteria or yeast.",
        "start": 360.44,
        "duration": 2.9
    },
    {
        "text": "That means you only have to grow part of the\nthing -- which is much easier!",
        "start": 363.34,
        "duration": 3.8
    },
    {
        "text": "But those antigens may not induce immunity\nby themselves – remember, for that to happen,",
        "start": 367.14,
        "duration": 4.67
    },
    {
        "text": "the lymphocyte with the exact right antigen\nreceptor must randomly come across the exact right antigen.",
        "start": 371.81,
        "duration": 5.71
    },
    {
        "text": "So many subunit vaccines use adjuvants, which",
        "start": 377.98,
        "duration": 2.38
    },
    {
        "text": "are substances that will attract our lymphocytes,\nusually by inducing some inflammation.",
        "start": 380.361,
        "duration": 5.359
    },
    {
        "text": "And that’s because inflammation naturally\nbrings in our immune cells",
        "start": 385.72,
        "duration": 3.7
    },
    {
        "text": "and makes the antigen/lymphocyte meet-cute more likely.",
        "start": 389.54,
        "duration": 3.26
    },
    {
        "text": "We use subunit vaccines for things like HPV\nor Hepatitis B.",
        "start": 392.81,
        "duration": 3.55
    },
    {
        "text": "Right now, there are dozens of subunit COVID-19\nvaccine candidates in the work, and a lot",
        "start": 396.36,
        "duration": 5.13
    },
    {
        "text": "of them are already scheduled for human trials\nlater this year.",
        "start": 401.49,
        "duration": 3.09
    },
    {
        "text": "And multiple other types of COVID-19 vaccines\nbased on even newer technologies are already entering human trials.",
        "start": 404.58,
        "duration": 7.26
    },
    {
        "text": "But if that’s the case...why is it going\nto take so long before one of these is available?",
        "start": 411.98,
        "duration": 5.51
    },
    {
        "text": "How long are we going to have to wait?!",
        "start": 417.49,
        "duration": 1.83
    },
    {
        "text": "No matter the technology, each vaccine needs\nto go through a trial process before getting",
        "start": 419.32,
        "duration": 4.9
    },
    {
        "text": "approved for human use.",
        "start": 424.22,
        "duration": 1.93
    },
    {
        "text": "That process is time-consuming for a reason,\nas it establishes both that the vaccine is",
        "start": 426.15,
        "duration": 5.32
    },
    {
        "text": "safe, and that it actually works.",
        "start": 431.47,
        "duration": 2.62
    },
    {
        "text": "So let’s walk through vaccine trials!",
        "start": 434.09,
        "duration": 2.09
    },
    {
        "text": "First, in the exploratory stage, scientists\nlooking to develop COVID-19 vaccines identify",
        "start": 436.18,
        "duration": 5.4
    },
    {
        "text": "possible candidates in the lab.",
        "start": 441.58,
        "duration": 2.32
    },
    {
        "text": "Once a promising candidate has been discovered,\nit’s time for the preclinical stage, where",
        "start": 443.9,
        "duration": 4.9
    },
    {
        "text": "the vaccines are tested on cells in culture\nand in animal models.",
        "start": 448.8,
        "duration": 4.63
    },
    {
        "text": "These animal models are carefully selected\nbased on whether a given animal gets sick",
        "start": 453.43,
        "duration": 4.11
    },
    {
        "text": "in a similar enough way to humans to be scientifically\ninformative.",
        "start": 457.54,
        "duration": 3.87
    },
    {
        "text": "Regular mice which is the main thing we use seem to be relatively immune\nto COVID-19, so there’s also an effort to",
        "start": 461.41,
        "duration": 6.61
    },
    {
        "text": "make them more human-ish in their response\nto the disease by giving them the human version",
        "start": 468.02,
        "duration": 5.07
    },
    {
        "text": "of a protein the virus uses to invade our\ncells.",
        "start": 473.09,
        "duration": 2.65
    },
    {
        "text": "But even the genetically-engineered mice we\nhave so far only develop mild symptoms to COVID-19.",
        "start": 475.74,
        "duration": 5.84
    },
    {
        "text": "So researchers have also been using naturally\nsusceptible animals, like Syrian hamsters,",
        "start": 481.8,
        "duration": 4.78
    },
    {
        "text": "Rhesus macaques, and ferrets.",
        "start": 486.74,
        "duration": 1.96
    },
    {
        "text": "Working through this menagerie can take time,\neven if you identify a candidate vaccine pretty quickly.",
        "start": 488.7,
        "duration": 5.0
    },
    {
        "text": "Once a candidate /does/ succeed in preclinical\ntrials, it can go on to Phase I, II and III human testing.",
        "start": 493.88,
        "duration": 6.8
    },
    {
        "text": "Phase I trials are done on groups of fewer\nthan a hundred volunteers.",
        "start": 501.0,
        "duration": 3.6
    },
    {
        "text": "At this stage, researchers find out whether\nthe vaccine candidate actually produces enough",
        "start": 504.61,
        "duration": 4.82
    },
    {
        "text": "of an immune response in a human being that\nit makes sense to move forward with a bigger study.",
        "start": 509.43,
        "duration": 5.57
    },
    {
        "text": "These trials both test to see whether there\nare any serious and significant side effects,",
        "start": 515.08,
        "duration": 4.319
    },
    {
        "text": "and they are also used to establish a safe\ndose for the vaccine -- though bigger trials",
        "start": 519.399,
        "duration": 4.191
    },
    {
        "text": "will provide more feedback there as well.",
        "start": 523.59,
        "duration": 2.55
    },
    {
        "text": "Phase II trials involve groups of several\nhundred volunteers and a more sophisticated",
        "start": 526.14,
        "duration": 4.76
    },
    {
        "text": "study protocol with a control group that gets\na placebo.",
        "start": 530.9,
        "duration": 3.09
    },
    {
        "text": "Here, scientists learn a lot more about the\nsafety, the right dose, and how those doses",
        "start": 533.99,
        "duration": 4.31
    },
    {
        "text": "will have to be timed out.",
        "start": 538.3,
        "duration": 1.62
    },
    {
        "text": "They also find out about the best way to administer\nit -- like through a nasal spray or an injection.",
        "start": 539.92,
        "duration": 5.19
    },
    {
        "text": "If all goes well, it’s time for Phase III,\nwhich involves double-blinded testing on groups",
        "start": 545.11,
        "duration": 5.2
    },
    {
        "text": "of thousands of participants.",
        "start": 550.31,
        "duration": 2.23
    },
    {
        "text": "Having a bigger group makes it possible to\nrule out dangerous, less common side effects",
        "start": 552.54,
        "duration": 4.44
    },
    {
        "text": "that may have slipped through the cracks in earlier trials.",
        "start": 556.98,
        "duration": 2.44
    },
    {
        "text": "But this is also the first trial that \naims to test how effective the vaccine will actually be.",
        "start": 559.42,
        "duration": 5.4
    },
    {
        "text": "Previous trials are looking to see if lymphocytes\nare responding, but without a placebo and",
        "start": 565.46,
        "duration": 4.54
    },
    {
        "text": "thousands of participants, you can’t actually\ncheck whether the infection rate actually",
        "start": 570.0,
        "duration": 4.49
    },
    {
        "text": "drops in the group that got the vaccine.",
        "start": 574.49,
        "duration": 2.39
    },
    {
        "text": "So the researchers need to give the vaccine\nto a lot of people.",
        "start": 576.88,
        "duration": 3.89
    },
    {
        "text": "Then they need to give them, and a placebo\ncontrol group that didn’t get the vaccine,",
        "start": 580.77,
        "duration": 4.74
    },
    {
        "text": "time to be in the world where they might naturally\nget infected to determine the efficacy of the vaccine.",
        "start": 585.51,
        "duration": 5.57
    },
    {
        "text": "If you make it this far, and it is effective, congrats!",
        "start": 591.26,
        "duration": 2.88
    },
    {
        "text": "A successful Phase III trial means that the\nvaccine can finally be approved for public use.",
        "start": 594.14,
        "duration": 5.24
    },
    {
        "text": "Normally, it takes a vaccine candidate ten\nto fifteen years to complete all of these testing phases.",
        "start": 599.62,
        "duration": 6.4
    },
    {
        "text": "Yeah, you heard that right.",
        "start": 606.22,
        "duration": 1.84
    },
    {
        "text": "I mean, think about it: for Phase III alone, you have\nto recruit /thousands/ of people and keep",
        "start": 608.06,
        "duration": 4.48
    },
    {
        "text": "tabs on all of them to make sure your candidate\nvaccine is working.",
        "start": 612.54,
        "duration": 3.96
    },
    {
        "text": "It isn’t a lack of money or researchers\nor work...TIME itself is a necessary part of the process.",
        "start": 616.5,
        "duration": 6.58
    },
    {
        "text": "The amazing good news though is that for COVID-19,\nthis process is being accelerated on an unprecedented scale.",
        "start": 623.56,
        "duration": 7.0
    },
    {
        "text": "At the time this video is in production, around\na hundred vaccine candidates are already being researched.",
        "start": 631.08,
        "duration": 4.7
    },
    {
        "text": "And only a few months after the first outbreak,\nmany of them have already entered Phase I",
        "start": 636.22,
        "duration": 4.26
    },
    {
        "text": "human trials or will do so very soon.",
        "start": 640.49,
        "duration": 2.42
    },
    {
        "text": "Even with this accelerated pace of development,\nit takes time to find the correct dose...or",
        "start": 642.91,
        "duration": 4.8
    },
    {
        "text": "doses...to make sure the vaccine will work,\nand be safe enough for us to tolerate.",
        "start": 647.71,
        "duration": 4.48
    },
    {
        "text": "That’s why you hear that one year to eighteen\nmonths figure.",
        "start": 652.19,
        "duration": 3.37
    },
    {
        "text": "From there...producing and distributing the\nvaccine will require a lot of thought and",
        "start": 655.56,
        "duration": 4.31
    },
    {
        "text": "work and also isn’t an instantaneous process.",
        "start": 659.87,
        "duration": 3.48
    },
    {
        "text": "Researchers think this is about as fast as\nwe can possibly go.",
        "start": 663.35,
        "duration": 3.799
    },
    {
        "text": "But you might be wondering, like, can’t\nwe do anything to speed things up?",
        "start": 667.149,
        "duration": 3.891
    },
    {
        "text": "The answer is yes, but it’s really complicated\nand there are tradeoffs and we’ve got a",
        "start": 671.04,
        "duration": 4.83
    },
    {
        "text": "whole episode on that coming up soon.",
        "start": 675.87,
        "duration": 1.69
    },
    {
        "text": "But we do also have short-term if not permanent solutions to\nthe problem of COVID-19….things like physical",
        "start": 677.56,
        "duration": 6.15
    },
    {
        "text": "distancing which has already saved...probably\nmillions of lives.",
        "start": 683.71,
        "duration": 3.66
    },
    {
        "text": "And in the slightly longer term, scientists\nare looking for treatments to help those who",
        "start": 687.37,
        "duration": 3.95
    },
    {
        "text": "are infected, including in the WHO-organized\nSOLIDARITY megatrial that we talked about",
        "start": 691.32,
        "duration": 5.23
    },
    {
        "text": "in this video appearing up in the corner.",
        "start": 696.55,
        "duration": 2.11
    },
    {
        "text": "A vaccine is our long-term hope, even though\nwe can’t be sure when any of these candidates will be ready.",
        "start": 698.66,
        "duration": 5.48
    },
    {
        "text": "The good news is, we have really effective\nways of creating new vaccines.",
        "start": 704.62,
        "duration": 3.98
    },
    {
        "text": "So we are pretty hopeful that one of these\nis going to come through.",
        "start": 708.61,
        "duration": 3.21
    },
    {
        "text": "And if there’s a good thing that’s coming\nout of this pandemic, it’s unprecedented",
        "start": 711.82,
        "duration": 3.48
    },
    {
        "text": "international cooperation between researchers\nwho want everyone, everywhere to be safe from this disease.",
        "start": 715.54,
        "duration": 5.96
    },
    {
        "text": "It shows that working together… actually\nworks.",
        "start": 721.84,
        "duration": 3.18
    },
    {
        "text": "Thanks for watching this episode of SciShow.",
        "start": 725.029,
        "duration": 1.851
    },
    {
        "text": "What we do here is only possible with the\nhelp of our patrons.",
        "start": 726.88,
        "duration": 3.24
    },
    {
        "text": "Our amazing community gets the chance to interact\nwith members of our team on our patron-only",
        "start": 730.12,
        "duration": 3.5
    },
    {
        "text": "Discord, and there’s other neat perks too\n-- like exclusive bloopers.",
        "start": 733.62,
        "duration": 3.33
    },
    {
        "text": "If you’re interested in helping out, check\nout patreon.com/scishow.",
        "start": 736.95,
        "duration": 4.99
    },
    {
        "text": "[♪OUTRO ]",
        "start": 741.94,
        "duration": 6.14
    }
]